Xenética
Servizo
![Foto de Xenética](/img/noimage.png)
![Foto de Oslo University Hospital](/img/noimage_org.png)
Oslo University Hospital
Oslo, NoruegaPublicacións en colaboración con investigadores/as de Oslo University Hospital (53)
2023
-
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2
Human Mutation, Vol. 2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Genome Medicine, Vol. 15, Núm. 1
-
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
Cancer Medicine, Vol. 12, Núm. 15, pp. 16142-16162
-
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
American Journal of Human Genetics, Vol. 110, Núm. 7, pp. 1200-1206
-
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
European journal of human genetics : EJHG, Vol. 31, Núm. 5, pp. 578-587
-
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
npj Breast Cancer, Vol. 9, Núm. 1
-
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Cancers, Vol. 15, Núm. 13
-
The impact of coding germline variants on contralateral breast cancer risk and survival
American Journal of Human Genetics, Vol. 110, Núm. 3, pp. 475-486
2022
-
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
Genome Medicine, Vol. 14, Núm. 1
-
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
Breast Cancer Research, Vol. 24, Núm. 1
-
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
European Journal of Cancer, Vol. 173, pp. 178-193
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes
JAMA Oncology, Vol. 8, Núm. 3
-
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
British Journal of Sports Medicine, Vol. 56, Núm. 20, pp. 1157-1170
-
Rare germline copy number variants (CNVs) and breast cancer risk
Communications biology, Vol. 5, Núm. 1, pp. 65
2021
-
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Breast cancer research : BCR, Vol. 23, Núm. 1, pp. 86
-
Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium
Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 4, pp. 623-642
-
Breast cancer risk genes - Association analysis in more than 113,000 women
New England Journal of Medicine, Vol. 384, Núm. 5, pp. 428-439
-
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
British Journal of Cancer, Vol. 124, Núm. 4, pp. 842-854